Instead of taking the traditional research route, the MVA Hackathon is turning the case of one child with Mosaic Variegated Aneuploidy (MVA) into a global research challenge. With the family’s permission, the child’s genomic and clinical data—information that would ordinarily be available only to a small group of clinicians and researchers—is being opened to a much larger community of geneticists, programmers, AI researchers, students, and citizen scientists. The idea is simple: give many more people and tools a chance to work on an extraordinarily difficult problem and see what they can find.

Participants first compete to identify the genetic variant already known to be driving the child’s condition, providing a real-world test of their methods. They can then tackle the unanswered question: how do those genetic changes disrupt normal biology, and might an existing approved drug counteract those effects? The proposed treatments are hypotheses rather than evidence that a drug works, but the hackathon offers a radically different model for rare-disease research—open one difficult case to the world and see what thousands of different minds and tools can uncover.